Suppr超能文献

基于卡尔曼滤波的新型胰岛素泵精度评估方法。

Kalman Filter-Based Novel Methodology to Assess Insulin Pump Accuracy.

机构信息

Air Liquide Healthcare, Explor Center, Gentilly, France.

Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 1138, Paris, France.

出版信息

Diabetes Technol Ther. 2019 Oct;21(10):557-565. doi: 10.1089/dia.2019.0147.

Abstract

Insulin pump or continuous subcutaneous insulin infusion (CSII) system is a widely adopted contemporary treatment for type 1 diabetes and is a major component of an artificial pancreas (AP). CSII accuracy is essential for glycemic control and to-date such metric has not been given sufficient study, especially at the range of the lowest basal rate. The gold-standard assessment method IEC (International Electrotechnical Commission) 60601-2-24 has some limitations. Our study presents a new accurate and reactive method for CSII system evaluation based on direct flow measurement. A leading-edge assessment method based on a double measurement approach utilizing a direct mass flow meter and a time-stamped microgravimetric bench test was combined with a Bayesian-based mathematical filter (Kalman). The performance of this new method was evaluated while assessing the delivery precision of an off-the-shelf insulin pump at several basal rates. The proposed methodology offers a double reading-volume and flow rate-which provides direct instantaneous flow rate. CSII dose errors were evaluated using mean absolute relative dispersion (MARD) at different time intervals windows over the whole test. The metrological aspect of the measurements and filtering performance were consistent. CSII precision is shown to be different in terms of the flow rate value: MARD (2 UI/h) = 12.7%, MARD (0.5 UI/h) = 20.4%, and MARD (0.1 UI/h) = 65.0%. MARD (2 UI/h) = 8.1%, (0.5 UI/h), MARD (0.5 UI/h) = 18.8%, and MARD (0.1 UI/h) = 18.4%. Instantaneous flow rate results highlight an irregular stroke-based delivery. This new method to assess insulin pump administration has been validated and highlights the current imprecision in insulin delivery, especially for the lowest basal rate, which is mainly used in pediatric cases and AP system delivery. This leading-edge method should be used to precisely compare several CSII performances in those contexts.

摘要

胰岛素泵或连续皮下胰岛素输注(CSII)系统是目前治疗 1 型糖尿病的广泛采用的方法,也是人工胰腺(AP)的重要组成部分。CSII 的准确性对于血糖控制至关重要,但迄今为止,这种指标尚未得到充分研究,尤其是在最低基础率范围内。金标准评估方法 IEC(国际电工委员会)60601-2-24 存在一些局限性。我们的研究提出了一种新的基于直接流量测量的 CSII 系统评估准确且反应灵敏的方法。一种基于双测量方法的先进评估方法,该方法利用直接质量流量计和时间标记微量天平测试相结合,并结合基于贝叶斯的数学滤波器(卡尔曼)。在评估几种基础率下市售胰岛素泵的输送精度时,评估了这种新方法的性能。该方法提供了双读数-体积和流量率-提供直接的瞬时流量率。使用不同时间间隔窗口的平均绝对相对分散度(MARD)评估 CSII 剂量误差。测量和过滤性能的计量方面是一致的。根据流量值,CSII 精度不同:MARD(2 UI/h)= 12.7%,MARD(0.5 UI/h)= 20.4%,MARD(0.1 UI/h)= 65.0%。MARD(2 UI/h)= 8.1%,(0.5 UI/h),MARD(0.5 UI/h)= 18.8%,MARD(0.1 UI/h)= 18.4%。瞬时流量结果突出了基于不规则冲程的输送。这种评估胰岛素泵给药的新方法已得到验证,并突出了目前胰岛素输送的不准确性,尤其是最低基础率,主要用于儿科病例和 AP 系统输送。在这些情况下,应使用这种先进的方法来精确比较几种 CSII 的性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验